Topic: Clolar
SILVER SPRING, Maryland (Reuters) - Genzyme Corp should run a new study before the company can win approval to promote a pediatric leukemia drug for older adults with an aggressive blood cancer, a U.S. advisory panel said on Tuesday. In a 9-3 ...
